JNK-IN-24 is a JNK inhibitor and an anti-metastatic cancer agent. It reduces the expression of JNK and MMP1 in cancer tissues induced by Scrib knockdown. JNK-IN-24 aids in the recovery of the ScribRNAi tumor disc phenotype and is applicable for studying various epithelial-derived cancers.
Molecular Weight:
360.79
CAS Number:
[2226808-28-0]
Formula:
C19H17ClO5
Target:
JNK|||MMP
T211561
* VAT and and shipping costs not included. Errors and price changes excepted